scholarly journals S1531 Therapeutic Challenges in Afferent Loop Syndrome Presenting as Recurrent Pancreatitis With Ascending Cholangitis

2021 ◽  
Vol 116 (1) ◽  
pp. S696-S696
Author(s):  
Michael Eiswerth ◽  
Dylan N. Gerlach ◽  
Charles F. Closson ◽  
Dipendra Parajuli
2019 ◽  
Vol 94 (2) ◽  
pp. 200-207
Author(s):  
Se Hee Lee ◽  
Myung-Hwan Kim ◽  
Hae In Kim ◽  
Ji Yeon Back ◽  
Yae Eun Park ◽  
...  

Medicine ◽  
2018 ◽  
Vol 97 (50) ◽  
pp. e13072
Author(s):  
Ra Ri Cha ◽  
Su Beom Cho ◽  
Wan Soo Kim ◽  
Jin Joo Kim ◽  
Jae Min Lee ◽  
...  

1998 ◽  
Vol 171 (3) ◽  
pp. 852-852 ◽  
Author(s):  
M Doherty ◽  
R S Perret

1981 ◽  
Vol 74 (5) ◽  
pp. 599-601 ◽  
Author(s):  
C. DALE BROWN ◽  
JOHN W. KRAUS

Radiology ◽  
2000 ◽  
Vol 216 (1) ◽  
pp. 142-145 ◽  
Author(s):  
Scott W. Wise

Endoscopy ◽  
2018 ◽  
Vol 50 (09) ◽  
pp. 891-895 ◽  
Author(s):  
Olaya Brewer Gutierrez ◽  
Shayan Irani ◽  
Saowanee Ngamruengphong ◽  
Hanaa Aridi ◽  
Rastislav Kunda ◽  
...  

Abstract Background Afferent loop syndrome (ALS) is traditionally managed surgically and, more recently, endoscopically. The role of endoscopic ultrasound-guided entero-enterostomy (EUS-EE) has not been well described. The aim of this study was to assess the technical and clinical success and safety of EUS-EE. Methods This was a multicenter, retrospective series at six centers in patients with ALS treated by EUS-EE. Data on patients treated with enteroscopy-assisted luminal stenting (EALS) at a single center were also collected. Results 18 patients (mean age 64.2 years, 72 % post-pancreaticoduodenectomy, 10 female) underwent EUS-EE. The most common symptoms were vomiting (27.8 %) and jaundice (33.3 %). Clinical success included resolution of symptoms in 88.9 % and improvement to allow hospital discharge in 11.1 %. Technical success was achieved in 100 % of cases, with a mean procedure time of 29.7 minutes. The most common procedure was a gastro-jejunostomy (72.2 %). Three adverse events (16.7 %) occurred (two mild, one moderate). When compared with data on EALS, patients treated with EUS-EE needed fewer re-interventions (16.6 % vs. 76.5 %; P < 0.001). Conclusion EUS-EE seems to be safe and effective in the treatment of ALS. Indirect comparison with EALS suggested that EUS-EE is associated with a reduced need for re-intervention.


2008 ◽  
Vol 78 (1-2) ◽  
pp. 91-92 ◽  
Author(s):  
Akio Ashida ◽  
Isao Tamura ◽  
Yutaka Kumagiri ◽  
Fumiyasu Fukano ◽  
Shinichiro Suzuki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document